Web Exclusives

  • Ixekizumab Approved for Adults with Psoriatic Arthritis
  • Biosimilar to Infliximab Approved for All Eligible Indications of Reference Drug
  • Tofacitinib and Tofacitinib Extended Release Approved for Adults with Psoriatic Arthritis
Read Article ›

Happy holidays and warmest wishes to you and your staff from the National Organization of Rheumatology Managers (NORM)!

Read Article ›


In a recent interview, Ms Zlatkus shared comments about her aspirations as President of NORM and Editor-in-Chief of RPM.

Read Article ›

Scott Gottlieb was recently confirmed as FDA Commissioner. It is believed that he would be able to swiftly execute changes that could help to accelerate drug approvals and lower drug prices to meet Trump’s goals.

Read Article ›

At the National Organization of Rheumatology Managers (NORM) 2017 Annual Conference, September 14-16, in Kansas City, MO, our expert speakers and educational sessions will help you further develop your management skills and successfully lead your practice into the future. Read Article ›

“We think this is one of the biggest survival gains ever reported in a trial of an adult solid tumor,” said Nicholas D. James, PhD, BSc, MBBS, FRCP, FRCR. Read Article ›

The National Organization of Rheumatology Managers (NORM) is pleased to announce that we have joined forces with several patient and provider groups, including the Coalition of State Rheumatology Organizations (CSRO), the American College of Rheumatology, the Global Healthy Living Foundation, the Rheumatology Nurses Society, and the Arthritis Foundation (AF) to form the Alliance for Transparent and Affordable Prescriptions (ATAP). Read Article ›

Dr Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs, and as Senior Advisor to the FDA Commissioner. Read Article ›

“This study’s findings—that adding antiandrogen therapy to the radiation typically used against recurrence reduces the incidence of metastasis, death from prostate cancer and overall deaths—will change the standard of care for patients experiencing a postoperative recurrence,” Dr Shipley added.

Read Article ›

Rheumatology Practice Management (RPM) will be providing a valuable new resource to our readers. Beginning in June, we will be featuring a Coding Corner section, with the goal of helping practice managers stay informed of pertinent issues concerning medical billing and coding, denials, and appeal protocols.

Read Article ›

In the coming year, NORM and Rheumatology Practice Management will strive to provide practice managers with the information and resources they need to deliver quality patient care.

Read Article ›

Page 2 of 5

Subscribe to
Urology Practice Management

Stay up to date with urology news & updates by subscribing to recieve the free UPM print publications or weekly e‑Newsletter.

I'd like to recieve: